ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
Huang H, Georganaki M, Conze LL, Laviña B, van Hooren L, Vemuri K, van de Walle T, Ramachandran M, Zhang L, Pontén F, Bergqvist M, Smits A, Betsholtz C, Dejana E, Magnusson PU, He L, Lugano R, Dimberg A.
Huang H, et al. Among authors: zhang l.
Neuro Oncol. 2022 Mar 12;24(3):398-411. doi: 10.1093/neuonc/noab181.
Neuro Oncol. 2022.
PMID: 34347079
Free PMC article.